Achieve Life Sciences, Inc. (ACHV) stock
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
$6.72+0.34 (+5.33%)
Close on Nov 6, 2026Market cap $691.51MP/E –Yield –
Achieve Life Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2019 it was $0.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | – |
See a number that looks wrong?